TCAP Gene Limb-Girdle Muscular Dystrophy autosomal recessive type 2G Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for TCAP Gene Limb-Girdle Muscular Dystrophy, autosomal recessive type 2G NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with TCAP Gene Limb-Girdle Muscular Dystrophy, autosomal recessive type 2G
Test Details
The TCAP gene is associated with Limb-Girdle Muscular Dystrophy, autosomal recessive type 2G (LGMD2G). LGMD2G is a rare genetic disorder that affects the muscles, causing progressive muscle weakness and wasting primarily in the muscles of the shoulders, upper arms, and hips.
NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses advanced sequencing technology to identify variations or mutations in the DNA that may be responsible for a particular genetic condition.
In the case of TCAP gene-related LGMD2G, NGS Genetic Testing can be used to identify mutations or variations in the TCAP gene that may be causing the disease. This can help in confirming the diagnosis, providing genetic counseling, and guiding treatment options for affected individuals and their families.
It’s important to note that NGS Genetic Testing is typically performed by healthcare professionals, such as geneticists or genetic counselors, and the results should be interpreted by a qualified healthcare provider. Additionally, genetic testing may not be available or appropriate for everyone, and the decision to undergo testing should be made in consultation with a healthcare professional.
Test Name | TCAP Gene Limb-Girdle Muscular Dystrophy autosomal recessive type 2G Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TCAP Gene Limb-Girdle Muscular Dystrophy, autosomal recessive type 2G NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TCAP Gene Limb-Girdle Muscular Dystrophy, autosomal recessive type 2G |
Test Details |
The TCAP gene is associated with Limb-Girdle Muscular Dystrophy, autosomal recessive type 2G (LGMD2G). LGMD2G is a rare genetic disorder that affects the muscles, causing progressive muscle weakness and wasting primarily in the muscles of the shoulders, upper arms, and hips. NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses advanced sequencing technology to identify variations or mutations in the DNA that may be responsible for a particular genetic condition. In the case of TCAP gene-related LGMD2G, NGS Genetic Testing can be used to identify mutations or variations in the TCAP gene that may be causing the disease. This can help in confirming the diagnosis, providing genetic counseling, and guiding treatment options for affected individuals and their families. It’s important to note that NGS Genetic Testing is typically performed by healthcare professionals, such as geneticists or genetic counselors, and the results should be interpreted by a qualified healthcare provider. Additionally, genetic testing may not be available or appropriate for everyone, and the decision to undergo testing should be made in consultation with a healthcare professional. |